Health In Tech, Inc.
- Open
- 1.15
- Day high
- 1.20
- Day low
- 1.07
- Prev close
- 1.13
- Volume
- 114K
- Mkt cap
- $74M
- P/E (TTM)
- —
- EPS (TTM)
- —
- P/B
- 3.4
- P/S
- 2.2
- Yield
- —
- Per share
- —
Health In Tech, Inc. (HIT) is a Technology company listed on NASDAQ. The stock is down 14% over the past year.
Health In Tech, Inc. (HIT) financials & analyst ratings
Fundamentals (TTM)
Source: exchange market data + company filings. Figures are trailing-twelve-month or as most recently reported. For informational purposes only — not investment advice.
HIT earnings date, history & EPS estimates
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 13, 2026 | $-0.03 | $-0.03 | -12.5% | $9M | +18.1% |
| Mar 25, 2026 | $-0.01 | $-0.01 | +0.0% | $8M | +3.4% |
| Jul 21, 2025 | $0.01 | $0.01 | +0.0% | $9M | +24.3% |
| Apr 14, 2025 | $0.02 | $0.01 | -50.0% | $8M | — |
| Mar 18, 2025 | — | $0.01 | — | $4M | — |
| Dec 31, 2024 | — | $-0.00 | — | $5M | — |
| Jun 30, 2024 | — | $0.01 | — | $5M | — |
| Mar 31, 2024 | — | $0.00 | — | $5M | — |
| Dec 31, 2023 | — | $0.02 | — | $5M | — |
| Sep 30, 2023 | — | $0.01 | — | $5M | — |
| Jun 30, 2023 | — | $0.01 | — | $5M | — |
| Mar 31, 2023 | — | $0.01 | — | $4M | — |
HIT insider trading activity (SEC Form 4)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 17, 2026 | Qian LinLindirector, 10 percent owner, officer: Chief Financial Officer | Tax | 28,725 | $1.04 |
| Jul 17, 2026 | Johnson Tim Donalddirector, 10 percent owner, officer: Chief Executive Officer | Tax | 47,217 | $1.04 |
| Jul 17, 2026 | Hasan Zain Syedofficer: Chief Growth Officer | Tax | 4,084 | $1.04 |
| Jul 10, 2026 | Shrestha Sanjay Kdirector | Grant | 18,867 | $1.06 |
| Jul 10, 2026 | Hayes Timothydirector | Grant | 18,867 | $1.06 |
| Jul 10, 2026 | Howard William D.director | Grant | 18,867 | $1.06 |
| Jun 18, 2026 | Hasan Zain Syedofficer: Chief Growth Officer | Tax | 4,045 | $1.05 |
| Jun 18, 2026 | Qian LinLindirector, 10 percent owner, officer: Chief Financial Officer | Tax | 28,451 | $1.05 |
| Jun 18, 2026 | Johnson Tim Donalddirector, 10 percent owner, officer: Chief Executive Officer | Tax | 46,768 | $1.05 |
| May 22, 2026 | Lockett Jonathan Delofficer: Chief Strategy Officer | Grant | 50,000 | — |
| May 18, 2026 | Johnson Tim Donalddirector, 10 percent owner, officer: Chief Executive Officer | Tax | 39,924 | $1.23 |
| May 18, 2026 | Hasan Zain Syedofficer: Chief Growth Officer | Tax | 4,205 | $1.23 |
| May 18, 2026 | Qian LinLindirector, 10 percent owner, officer: Chief Financial Officer | Tax | 23,324 | $1.23 |
| Apr 17, 2026 | Hasan Zain Syedofficer: Chief Growth Officer | Tax | 3,448 | $1.50 |
| Apr 17, 2026 | Johnson Tim Donalddirector, 10 percent owner, officer: Chief Executive Officer | Tax | 35,140 | $1.50 |
Source: HIT SEC Form 4 filings, latest Jul 17, 2026. For informational purposes only — not investment advice.
See the full HIT insider & 13F page →Health In Tech, Inc. company profile
Overview
Health In Tech, Inc. (NASDAQ:HIT) is an insurance technology platform company founded in 2014 and headquartered in Stuart, Florida. The company went public in December 2024, positioning itself as a technology-driven solution provider in the healthcare insurance sector. Health In Tech focuses on serving small to medium-sized businesses with innovative insurance products and digital platforms designed to streamline healthcare benefit management and reduce costs for employers.
Business
Health In Tech operates in the insurance technology (insurtech) sector, specifically targeting the healthcare benefits market for small and medium-sized businesses. The healthcare insurance industry in the United States is characterized by complex administrative processes, high costs, and fragmented systems that often burden employers seeking to provide health benefits to their employees. The company's core offering is the eDIYBS (enhanced Do It Yourself Benefit System), a web-based Software-as-a-Service platform that enables insurance brokers to quote health insurance for small to medium-sized employers. This platform incorporates AI-driven underwriting capabilities that can process complex data submissions and present information in standardized formats, reducing processing time by 70-80% according to management. Health In Tech operates through two primary business segments that generate distinct revenue streams: 1. Program Fee Revenue (approximately 66% of total revenue): The company acts as a program manager, creating customized healthcare plans for small businesses. This includes reference-based pricing models, group insurance captives, community health plans, and association health programs. In this capacity, Health In Tech earns fees for designing and managing these specialized insurance products. 2. Underwriting Model Revenue (approximately 34% of total revenue): The company functions as an underwriter, earning a percentage of premiums from the insurance policies it underwrites. This involves assessing risk and setting pricing for healthcare plans, particularly for businesses with 150+ employees. Additional products include the Health Intelligence (HI) Card, designed to streamline medical records and claims management, and the HI Performance Network, which provides access to hospital facilities with Medicare-based reimbursement pricing. The company is also developing an Exchange platform to offer comprehensive insurance solutions to a broader market including healthcare systems, brokers, and insurance companies.
Revenue model
Health In Tech generates revenue through two primary business models that reflect its dual role in the healthcare insurance ecosystem. The program fee model represents the larger revenue stream, where the company earns fees by creating and managing specialized healthcare plans for small businesses. These fees are typically charged as a percentage of premiums or as fixed administrative fees for plan design, implementation, and ongoing management services. Customers in this segment are primarily small business employers who pay Health In Tech to design cost-effective healthcare benefit programs that often utilize alternative funding mechanisms like reference-based pricing or captive insurance arrangements. The underwriting model generates revenue through premium-based commissions, where Health In Tech acts as an insurance underwriter and earns a percentage of the premiums collected from policies it underwrites. This model requires the company to assess risk, set pricing, and potentially bear some insurance risk. The customers are employers seeking health insurance coverage, typically those with 150 or more employees. Several factors influence the company's margins and profitability. Positive margin drivers include the scalability of the SaaS platform, which allows the company to serve more customers without proportional increases in operational costs, and the AI-driven automation that reduces manual underwriting time and labor costs. The company's focus on alternative insurance arrangements like reference-based pricing can also provide cost advantages that translate to higher margins. Margin pressures come from increased competition in the insurtech space, regulatory changes in healthcare insurance that may require costly compliance adjustments, and the need for continuous technology investment to maintain platform competitiveness. Additionally, as an underwriter, the company faces actuarial risk where poor risk assessment could lead to higher-than-expected claims costs. The company's expansion into larger employer segments also requires more sophisticated underwriting capabilities and potentially higher operational costs.
Risks & safety
Health In Tech demonstrates a moderate margin of safety with strong liquidity but elevated valuation metrics that suggest limited downside protection. • Liquidity and Solvency: Strong cash position of $7.6 million with minimal debt (debt-to-equity ratio of 0.013), providing substantial runway for operations. Current ratio of 2.31 indicates solid short-term liquidity coverage. • Cash Flow: Positive operating cash flow of $527,353 in Q1 2025, though this follows negative operating cash flow of -$531,167 in Q4 2024, indicating some volatility in cash generation patterns. • Valuation Concerns: Price-to-earnings ratio of 18.1x appears reasonable, but price-to-book ratio of 2.55x suggests the stock trades at a premium to tangible assets. EV/EBITDA of 11.7x is moderately elevated for a small technology company. • Graham Metrics: Graham number of 0.23 and Graham net-net of 0.036 both well below current price levels, indicating the stock does not meet traditional value investing criteria for margin of safety. • Scale Risk: Small market capitalization of approximately $34 million creates liquidity risk and vulnerability to market volatility, while limited operating history as a public company adds uncertainty to financial projections.
Recent development
Over the past few years, Health In Tech has undergone significant strategic evolution, transitioning from a private company focused primarily on small business insurance to a public technology platform with expanded market reach and enhanced capabilities. The company's most significant milestone was completing its IPO in December 2024, which provided capital for growth initiatives and technology investments. This public offering enabled the company to invest substantially in IT infrastructure, cybersecurity, and platform development. Technology advancement has been a central focus, with the company launching AI-backed underwriting capabilities that can automatically parse complex data submissions and reduce processing time by 70-80%. The enhanced eDIYBS platform now incorporates third-party medical data vendors and proprietary data parsing technology to streamline risk assessment and underwriting processes. The company has expanded its market reach significantly, moving beyond its traditional small business focus to target mid-sized and large businesses with over 1,000 employees. This expansion required developing more sophisticated underwriting capabilities and launching new products like Spec & Aggregate stop-loss healthcare plans designed for larger employer groups. Strategic partnerships have also been a key development area, including a collaboration with DialCare for telehealth services and expansion of the broker network to 459 active brokers, more than doubling from the previous year. The company has also strengthened its leadership team with experienced professionals and added new board members like Sanjay Shrestha. Product development has included the introduction of the Health Intelligence Card for personal health data management and the development of an Exchange platform designed to serve healthcare systems, brokers, and insurance companies with comprehensive insurance solutions. These initiatives represent the company's strategy to diversify beyond its core small business market and create additional revenue streams.
HIT company profile · for informational purposes only — not investment advice.
Track HIT with Drillr
SEC filings, earnings calls, insider activity, alt-data signals — all queryable through Drillr's AI terminal and MCP API.
Try Drillr for free